A randomized, double-blind, placebo-controlled phase 2 pilot trial evaluating a novel, vaginal softgel capsule containing solubilized estradiol

OBJECTIVE: The aim of the study was to evaluate the safety and efficacy of vaginal estradiol (E(2)) softgel capsules for moderate-to-severe symptoms of vulvar and vaginal atrophy (VVA). Previous phase 1 studies showed lower systemic estrogen concentrations with this softgel capsule compared with an...

Descripción completa

Detalles Bibliográficos
Autores principales: Pickar, James H., Amadio, Julia M., Hill, John M., Bernick, Brian A., Mirkin, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott-Raven Publishers 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848733/
https://www.ncbi.nlm.nih.gov/pubmed/26836245
http://dx.doi.org/10.1097/GME.0000000000000592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848733/
https://www.ncbi.nlm.nih.gov/pubmed/26836245
http://dx.doi.org/10.1097/GME.0000000000000592

Ejemplares similares